Galderma

Swiss dermatology company Galderma has agreed to acquire skincare brand ZO Skin Health in a deal valued at $1.5 billion, according to the Wall Street Journal. The acquisition would expand Galderma's portfolio in the fast-growing professional skincare market, and the size of the transaction is drawing attention across the health and beauty industries.

Swiss dermatology group Galderma has agreed to acquire ZO Skin Health, the skincare brand founded by celebrity dermatologist Zein Obagi, in a deal worth around $1.5 billion, sources told Reuters. The acquisition would expand Galderma's consumer skincare portfolio alongside its injectables and dermatology treatments. Details on timing and regulatory approval have not yet been officially confirmed by either company.

Swiss dermatology company Galderma has agreed to acquire US skincare firm ZO Skin Health in a deal worth $1.5 billion. The move expands Galderma's consumer skincare portfolio in the US market. The acquisition is drawing attention from healthcare investors and industry watchers tracking consolidation in the dermatology and aesthetics sector.

Swiss dermatology company Galderma has agreed to acquire skincare brand ZO Skin Health in a deal valued at 1.5 billion dollars. The move strengthens Galderma's position in the fast-growing professional skincare market, adding ZO's physician-dispensed product range to its portfolio of dermatology and aesthetic treatments.

Swiss dermatology company Galderma has signed an agreement to acquire skincare brand ZO Skin Health from Blackstone and the Obagi family in an all-cash deal valued at $1.5 billion. The transaction is expected to close in late 2026 or early 2027, expanding Galderma's consumer skincare portfolio.